Expansion and Innovation Elanco is actively expanding its presence in Indianapolis, including opening a new global headquarters and enhancing its R&D capabilities. This strategic growth indicates increased capacity for developing and delivering innovative animal health solutions, presenting opportunities to introduce complementary products and technologies.

Regulatory Approvals The recent receipt of Emergency Use Authorization from the FDA for Credelio to treat New World screwworm infestations demonstrates Elanco’s focus on addressing critical animal health needs with innovative treatments. This opens doors for sales of specialized products in emerging or underserved markets.

Community Engagement Elanco actively partners with community organizations like IndyHumane and launches awareness campaigns such as National Parvo Awareness Day, highlighting its commitment to animal welfare and community presence. These initiatives create opportunities to build trust and expand outreach to pet owners and veterinarians.